Non-Invasive Spinal Cord Stimulation for Neurological Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if non-invasive spinal cord stimulation (Transcutaneous Spinal Stimulation) can improve walking in individuals with neurological conditions such as cerebral palsy and stroke. Participants will engage in physical and gait training, either alone or combined with spinal stimulation, to compare the effects. The study focuses on reducing muscle tightness and enhancing movement, while also collecting participant feedback on their experiences. It is suitable for those with a neurological condition who can walk 20 yards (with or without assistance) and commit to multiple weekly sessions over several months. As an unphased trial, this study offers participants the chance to contribute to pioneering research that could enhance mobility treatments for neurological conditions.
Do I need to stop my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you have an implanted stimulator or drug delivery device, you cannot participate in the trial.
What prior data suggests that this spinal stimulation technique is safe for neurological disorders?
Research has shown that transcutaneous spinal stimulation, which uses electrical currents on the skin without surgery, is generally safe. Studies have found it to be well-tolerated and beneficial in improving function for those with spinal cord injuries. For instance, one study found that this stimulation improved hand and arm functions without causing serious side effects. Another study demonstrated that using this therapy both in clinics and at home safely enhanced upper body strength and function in individuals with long-term spinal cord injuries. No major safety issues have been reported so far, making it a promising option for improving physical abilities in people with neurological conditions.12345
Why are researchers excited about this trial?
Unlike conventional treatments for neurological disorders, which often rely on physical therapy alone, the approach being explored here combines intensive gait training with non-invasive spinal cord stimulation. This spinal stimulation is delivered transcutaneously, meaning it’s done through the skin without surgery, which could make it more accessible and less risky. Researchers are excited because this combination could enhance nerve function and improve walking capabilities more effectively than standard physical therapy. The hope is that this method may offer a more robust and rapid recovery pathway for individuals struggling with walking impairments due to neurological issues.
What evidence suggests that this trial's treatments could be effective for improving walking function in neurological disorders?
Research has shown that gait training, one of the treatments in this trial, can greatly improve walking in people with nerve-related issues. Studies have found that practicing walking at a higher intensity can boost mobility and speed, especially for stroke patients. Working harder on walking tasks can enhance balance and overall walking ability.
Transcutaneous spinal stimulation, another treatment option in this trial, sends electrical signals to the spine without surgery and has also shown promise. It has been widely used for people with spinal cord injuries and has led to better movement abilities, such as walking. While results can vary, some individuals experience significant improvements in their ability to move. This suggests that spinal stimulation can be a helpful tool for improving walking in those with nerve-related conditions.678910Who Is on the Research Team?
Katherine M Steele, PhD
Principal Investigator
University of Washington
Are You a Good Fit for This Trial?
This trial is for people with neurological conditions like cerebral palsy who can walk 20 yards and follow simple instructions. They must be medically stable, able to attend up to five therapy sessions weekly, and have support for the 11-month study period. Those with severe medical issues, uncontrolled seizures, recent musculoskeletal surgeries, or implanted devices are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Initial baseline period to assess participants before intervention
First Intervention
Participants undergo either intensive training only or intensive training combined with spinal stimulation
Washout
A period with no intervention to eliminate effects of the first intervention
Second Intervention
Participants undergo the intervention they did not receive during the first intervention phase
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Gait Training
- Transcutaneous Spinal Stimulation
Gait Training is already approved in United States, European Union, Canada for the following indications:
- Spinal Cord Injury
- Cerebral Palsy
- Stroke Rehabilitation
- Spinal Cord Injury
- Neurological Rehabilitation
- Spinal Cord Injury
- Stroke Rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
Seattle Children's Hospital
Collaborator